4//SEC Filing
Seymour Albert 4
Accession 0000899243-22-030658
CIK 0001661998other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 4:05 PM ET
Size
12.2 KB
Accession
0000899243-22-030658
Insider Transaction Report
Form 4
Seymour Albert
Chief Scientific Officer
Transactions
- Award
Restricted Stock Units
2022-09-06+14,000→ 14,000 total→ Common Stock (14,000 underlying) - Award
Employee Stock Option (Right to Buy)
2022-09-06+23,000→ 23,000 totalExercise: $2.18Exp: 2032-09-06→ Common Stock (23,000 underlying)
Footnotes (3)
- [F1]The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following September 6, 2022.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
- [F3]The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of September 6, 2022 so that such RSUs will become fully vested on September 6, 2025.
Issuer
Homology Medicines, Inc.
CIK 0001661998
Entity typeother
Related Parties
1- filerCIK 0001735324
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 4:05 PM ET
- Size
- 12.2 KB